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Abstract: The recent advances in the synthesis of carborane and boronic ester-substituted tetrapyrroles (porphyrins,
porphyrazines, and phthalocyanines) are reviewed together with their possible utilization as agents for photodynamic
therapy (PDT) and boron neutron capture therapy of cancer (BNCT) as well as dual PDT/BNCT sensitizers.
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1. Introduction
The basic tetrapyrrole skeleton of porphyrin, found in many natural pigments, is probably one of the oldest
bioorganic structures known to man. 1 Porphyrazines, structural analogs of natural porphyrins, are small-ring
tetrapyrrolic macrocycles in which the meso positions contain nitrogen atoms instead of CH groups. They largely
retain the flexibility of the porphyrin’s core and show intense to very intense absorbance in the ‘therapeutic
window’. 2
Apart from their uses as dyes or pigments, phthalocyanines receive great interest due to their special
properties. They show exceptional thermal and chemical stability. The conjugated π system, containing 18
electrons, leads to very intense absorption bands in the ultraviolet region at around 300–350 nm and in the
visible region at around 700 nm with high extinction coefficients. 3 In addition, their properties can be altered
through the addition of substituents to the periphery of the macrocycle or binding of axial ligands to central
metal ion.
On the basis of their photophysical properties, both naturally occurring and synthetic tetrapyrrole
derivatives have recently found specific biomedical applications, particularly in the field of photodynamic therapy
(PDT). 4
PDT is a minimally invasive treatment that destroys target cells in the presence of oxygen when light
irradiates a photosensitizer, generating highly reactive singlet oxygen. Singlet oxygen then attacks cellular
targets, causing destruction through direct cellular damage, vascular shutdown, and activation of an immune
response against targeted cells. 5 PDT requires 3 elements to generate singlet oxygen: a photosensitizer,
appropriate light, and oxygen. The wavelengths of the light that are typically used for PDT are in the red
or near infrared spectral range as these wavelengths exhibit a greater penetration depth into most human
tissues and are not absorbed by normal tissue constituents. 6
For many decades, interest in medical application of boron chemistry has centered primarily on the boron
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neutron capture therapy (BNCT) approach to cancer treatment. 7 BNCT is based on the nuclear capture and
fission reactions that occur when boron-10 ( 10 B), which is a nonradioactive constituent of the natural elemental
boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles ( 4 He)
and recoiling lithium-7 ( 7 Li) nuclei. 8 The short travel range (5–9 Å) of the fragments combined with the local
accumulation of B permits the destruction of selected tissue areas. 8−11
The success of boron neutron therapy application depends on the properties of the boron delivery
agents. An efficacious boron delivery agent should display the following characteristics: 1) low systemic toxicity
and normal tissue uptake with high tumor uptake and concomitantly high tumor/brain and tumor/ blood
concentration ratios (above 3–4:1); 2) a minimum concentration of 20–35 µ g of

10

B nuclei per gram of tumor;

3) rapid clearance from blood and normal tissues and persistence in the tumor during BNCT. 8,12
The major challenges in compound development for BNCT have been the requirements for selective
tumor targeting and the delivery of therapeutic boron concentrations to tumors with minimal normal tissue
toxicity. 12,13 The polyhedral borane anions and many of the various carboranes appear to meet the requirement
of possessing high boron percentages, and, for this reason, there has been significant effort in the area of
compound development directed toward the incorporation of such entities into organic structures. 10
The majority of known carboranes resemble regular icosahedron C 2 B 10 cages. A special attribute of
icosahedral C 2 B 10 cages is their nearly spherical shape with a spatial requirement only slightly larger than
that of a rotating phenyl ring, allowing replacement of aryl rings with carboranyl units in biologically active
molecules while substantially retaining their general properties. Moreover, one can fine-tune the behavior of
such species by varying the type of carborane system and by introducing one or more metal centers, either as
part of a metallacarborane cage or as exopolyhedral substituents. Another very important property of C 2 B 10
clusters is their previously noted hydrophobicity, which increases in the order of o− > m− > p -carborane (with
decreasing dipole moment). 7
Many new types of compounds containing both tetrapyrrole macrocycles and polyhedral boron units
in a single molecule have been prepared over the past 20 years 2,10,12,14,15 as this class of compounds shows
several advantages for use as BNCT delivery vehicles, including: 1) their demonstrated tumor selectivity and
long retention times in tumors; 2) low dark toxicities; 3) their ability for sensitizing the production of cytotoxic
oxygen species on light activation, which constitutes the basis for their use in PDT 4,12,16 of tumors; 4) their
ability for DNA and RNA binding and for inducing cell apoptosis upon brief exposure to light; 5) their fluorescent
properties, which facilitate the detection of tissue-localized boron and treatment planning; 6) their ability to form
stable in vivo complexes with a variety of metal ions while retaining their biodistribution and pharmacokinetic
properties. 16−18
2. Carborane-substituted porphyrins
The potential for medical application of porphyrin-like compounds is of interest for several reasons in addition
to the cytotoxicity toward tumor cells: they accumulate in cells via binding of their planar aromatic systems
to DNA; they can form stable complexes with a variety of metal ions; and their fluorescence makes them ideal
for spectroscopic detection and imaging. Furthermore, appending polyhedral boron cages to porphyrins adds
even greater versatility, opening up possible applications in BNCT. 8,14,19,20 The pharmacological properties of
carboranyl porphyrins and the utilization of compounds of this type in BNCT and PDT have been already
documented in reviews. 12,14
951
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Polyamines are known to be essential for cell growth and differentiation, and due to an upregulated
polyamine transport system they accumulate in high concentrations in tumor cells. Thus, conjugation of
polyamines to a boron-containing porphyrin could potentially increase boron uptake into tumor cells, favoring
DNA binding and overall BNCT efficiency. More recently, synthesis of several polyamine conjugates of a tri(pcarboranylmethylthio)tetra- fluorophenylporphyrin (1–9) has been reported (Scheme 1).

21

Scheme 1. Synthesis of compounds 1–9.

These polyamine conjugates showed low dark cytotoxicity and low phototoxicity. All polyamine conjugates, with one exception, showed higher uptake into human glioma T98G cells (up to 12-fold) than the PEG
conjugate, and they localized preferentially in the cell endoplasmic reticulum, Golgi, and lysosomes. 21
Three carboranyltetraphenylporphyrins containing 40 or 80 boron atoms were synthesized and evaluated
for their biodistribution and toxicity in EMT-6 tumor-bearing mice. Copper(II) meso-5,10,15,20-tetrakis[3methoxy-4-(o-carboranylmethoxy)phenyl] porphyrin (10) and copper(II) meso-5,10,15,20-tetrakis[3-hydroxy-4(o-carboranylmethoxy)phenyl]porphyrin (11) are B 40 congeners with different lipophilicities, each less than their
952
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B 80 congener, copper(II) meso-5,10,15,20-tetrakis[m-(3,5-di-o-carboranylmethoxybenzyloxy)phenyl]porphyrin
(12) (Figure 1). It was demonstrated that porphyrin 10 may rank among the most clinically promising
carboranyl porphyrins ever made to deliver
in vivo.

10

B to tumors for BNCT that has also been tested for its toxicity

22

Figure 1. Structures of compounds 10–12.

In most of the porphyrins, carborane cages are linked to the porphyrin macrocycle via the meso-phenyl
groups. The study by Vicente and colleagues 23 showed for the first time that multiple boron clusters can be
readily incorporated into the same porphyrin macrocycle, linked to both the β -pyrrolic positions and the mesophenyl rings. These β - carboranylporphyrins of high boron content (32%–43%) (14,15) were prepared by the
condensation reaction of novel carboranylpyrrole 13 with benzaldehyde under Lindsey conditions (Scheme 2).
Since high amounts of boron are needed for effective BNCT, porphyrins of high boron content are
potentially promising delivery vehicles for this therapy. Porphyrins 16–19, containing 8 carborane cages linked
via carbon–carbon bonds to the meso-phenyl groups of the porphyrin ring, were synthesized in moderate yields
(Figure 2). While the closo-carboranylporphyrins 16 and 17 are highly hydrophobic and completely insoluble
in water, the octa-anionic nido analogs 18 and 19 show good solubility in polar solvents (e.g., water, methanol,
DMSO) due to their amphiphilic nature. 24
The results of that study indicated, for the first time, that a porphyrin derivative bearing 8 nido-carborane
groups linked to the porphyrin platform via carbon–carbon bonds can still accumulate intracellularly and shows
similar low dark toxicity to that found for related carboranylporphyrins of lower boron content, and therefore
might have promise for application in BNCT. 24
Tetrabenzoporphyrins, as the name indicates, contain 4 β ,β -fused benzene rings on a porphyrin macrocycle, and thus belong to the family of π -extended porphyrins. Tetrabenzoporphyrins have an advantage over porphyrins as PDT sensitizers in that they typically absorb strongly in the red region of the optical spectrum. The
first water-soluble carboranyl-tetrabenzoporphyrin (23) was prepared in 43% overall yield as shown in Scheme
3. Condensation of butanopyrrole (20) and carboranyl-benzaldehyde (21) under Lindsey-type conditions gave
953
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Scheme 2. Synthesis of compounds 14 and 15.

Figure 2. Structures of compounds 16–19.

the corresponding carboranylporphyrin. Insertion of Cu(II) was achieved quantitatively with copper(II) chloride
in refluxing toluene for 4 h. Oxidation of the Cu(II)–porphyrin to tetrabenzoporphyrin 22 was accomplished
in 75% yield using 8 equiv. of DDQ in refluxing toluene. Demetalation of Cu(II)–tetrabenzoporphyrin 22
occurred upon treatment with concentrated H 2 SO 4 at room temperature. The metal-free tetrabenzoporphyrin
was converted into the water-soluble nido-carboranyl derivative 23 in 95% overall yield by deboronation of
the carborane cages in the presence of tetra-butylammonium fluoride, followed by ion exchange using a Dowex
50WX2-100 resin in the sodium form. 25
954
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Scheme 3. Synthesis of compounds 22 and 23.

It was revealed that this tetrabenzoporphyrin compound accumulated within human glioblastoma T98G
cells to a significantly higher extent than a structurally related nido-carboranylporphyrin and localized preferentially in the cell lysosomes. The data of animal toxicity studies showed that both compounds are nontoxic even
at a dose of 160 mg/kg, administered intraperitoneally as a single injection at a concentration of 4 mg/mL. 26
Recently, metallacarboranes, and in particular the cobaltabisdicarbollide anion, have received much
interest 27 because these complexes contain a larger number of boron atoms than the carboranes and the closododecaborate anions and are water-soluble in the form of sodium or potassium salts while still maintaining the
hydrophobic character needed for crossing cellular membranes. Furthermore, they show remarkable stability in
the presence of acids, moderate bases, radiation, and high temperature.
Several porphyrincobaltacarborane conjugates (24–28) that contained 4 to 16 carborane clusters per
porphyrin macrocycle were prepared in excellent yields (90%–97%) by means of a ring-opening reaction of
the zwitterionic cobaltacarborane [3,3’-Co(8-C 4 H 8 O 2 –1,2-C 2 B 9 H 10 ) (1’,2’-C 2 B 9 H 11 )] (Figure 3). 28 It was
demonstrated that the cellular uptake of this series of conjugates depends on the number of cobaltacarborane
moieties at the porphyrin periphery and their distribution, amphiphilic character, and aggregation properties.
Conjugates 25 and 27, bearing 2 adjacent and three 3,5-dicobaltacarboranephenyl groups, respectively, accumulated the most within HEp 2 cells, showed very low dark toxicity and phototoxicity, and are, therefore, the
most promising BNCT agents. 28
955
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Figure 3. Structures of compounds 24–28.

The total syntheses of 5 new porphyrin-cobaltacarborane conjugates (31–35) have been achieved in
88%–98% yields in a single-step ring-opening reaction between a nucleophilic meso-pyridyl-containing porphyrin
(29) and zwitterionic cobaltacarborane [3,3’-Co(8-C 4 H 8 O 2 -1,2-C 2 B 9 H 10 ) (1’,2’-C 2 B 9 H 11 )] (30) (Scheme 4).
These unique zwitterionic compounds have 1 to 4 cobaltabisdicarbollide anions conjugated to the porphyrin

Scheme 4. Synthesis of compounds 31–35.
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macrocycle via (CH 2 CH 2 O) 2 chains. The cellular uptake, cytotoxicity, and subcellular localization of cobaltacarboraneporphyrins 31–35 were investigated in human HEp 2 cells. It was found that the number and distribution of
cobaltacarborane residues linked to the porphyrin macrocycle has a significant effect on the cellular uptake of
the conjugates. 29
It was discovered that this easy, efficient, high yielding reaction also proceeds with phenol-substituted
porphyrins as the nucleophilic species. The conjugation of 5,10,15,20-tetra(4-hydroxyphenyl)-porphyrin with
cobaltacarborane was achieved in 85% yield upon activation of the porphyrin hydroxyl groups with either cesium
carbonate or potassium carbonate in anhydrous acetone, thus affording conjugate 36 as cesium or potassium
salts (Figure 4). 30

Figure 4. Structure of compound 36.

The second strategy for preparing the boronated porphyrin derivatives is the direct functionalization of a preformed macrocycle (protoporphyrin-type or meso-tetraphenylporphyrin-type). Protoporphyrin
IX [i.e. bis(α -methyl-β -pentylethylether) protoporphyrin IX (37) and bis(α -methyl-β -dodecanylethylether)protoporphyrin IX] bearing polyhedral borane anions (B 12 H 11 SH −2 or B 12 H 11 OH −2 ) (38–41) was synthesized with reasonable yields (Figure 5). Modification of the protoporphyrin IX structure was achieved by
variation of the lengths of the alkyl chains (pentyl and dodecanyl) attached through ether linkages to the former
vinyl groups. The goal of this modification was to develop boronated porphyrins with chemical and physical
properties that differed from those of protoporphyrin IX. Importantly, these new structurally varied boronated
957
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porphyrins displayed a wide spectrum of water solubilities and surprising spectroscopic properties with extremely stable and nontoxic closo-borane anions. Furthermore, it was found that the boronated porphyrins
exhibited low cytotoxicities and high levels of accumulation and induced potent PDT effects with a variety of
cancer cell lines. 31

Figure 5. Structures of compounds 37–41.

3. Porphyrins with boronic ester groups
The synthesized porphyrinyl boronic acid esters have proven to be valuable coupling partners in Suzuki couplings,
leading to the synthesis of a broad variety of intrinsically axially chiral β , β ’-linked bisporphyrins. 32,33 A recent
paper described a variable, straightforward synthetic procedure for the construction of β ,meso-linked porphyrin
multichromophores in good to excellent yields. 34 In a Suzuki-type coupling reaction β -borylated 5,10,15,20tetraarylporphyrins (TAPs) served as versatile building blocks for the preparation of a plethora of directly
linked, unsymmetrically substituted di- and triporphyrins. Besides their interesting photophysical properties,
the trimeric porphyrin arrays show particularly exciting stereochemical features. The established protocols thus
opened a convenient entry into the synthesis of achiral and chiral unsymmetrically substituted β ,meso-linked
oligoporphyrins, e.g., for applications in biomedicine or nonlinear optics. 34
Starting with 5,10,15-homosubstituted precursors (43) and porphyrin boronic acid esters (42) as the
coupling partners, the simple Cs-symmetric A3-β TAP-type bisporphyrins 44a–44c bearing 3 identical aryl or
alkyl substituents in the meso-linked moiety were generated in good yields (Scheme 5). Full metalation of the
dimers 44 to give the respective zinc(II), nickel(II), or copper(II) complexes 44a–44c was easily achieved in
yields higher than 92%. 34
The established strategy also offers an easy entry into the design of trimeric porphyrins featuring 2 direct
porphyrin–porphyrin axes: starting from dibrominated 5,15-diphenylporphyrin (45), the β TAP-5,15-A2-β TAP
trimer (46) was synthesized, in which 2 identical TAPs were β -linked to the central porphyrin macrocycle in a
linear array (Scheme 6). 34
As expected, the functionalized dimers were proved to be versatile precursors for the construction of
highly complex porphyrin trimers (Scheme 7). 34
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Scheme 5. Synthesis of compound 44.

Scheme 6. Synthesis of compound 46.
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Scheme 7. Synthesis of compound 49.

4. Carborane-substituted porphyrazines
Porphyrazines, with chemical and physical properties not easily accessible to porphyrins, are readily synthesized
through template cyclotetramerization of an appropriate dinitrile derivative. As, in principle, boron-containing
porphyrazines may conjugate the photosensitizing properties of the macrocycle with the BNCT sensitizing
capability of the boronated substituents, they have potential in multiple approaches for anticancer therapy. 35
An effective strategy to synthesize a new family of boronated porphyrazines to be delivered through the
membrane of cancerous tissues as such or with the help of liposomes was developed recently. The synthesis and
the basic physicochemical properties of neutral octa-closo-carboranyl-alkylthio-porphyrazine as well as of their
water-soluble counterpart (50) were obtained by mild deboronation of the closo-polyedra (Figure 6). 35
5. Porphyrazines with boronic ester groups
Formation of boronic ester from difunctional boronic acid with diols has been used for the construction of discrete
cycles and cages. 36,37 Although the presence of 2 oxygen donor atoms is generally sufficient to complete boronic
ester formation, an additional N donor has also been effectively used to form a further B–N bond. 38 Studies
960
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showed that, in such a case, the boron atom is tetra-coordinated and forms a dative bond with the nitrogen
atom. 39

Figure 6. Structure of compound 50.

Phenylboronic acid esters of an unsaturated precursor 1,2-dicyano-1,2-bis(2-hydroxyethylthio) ethylene
and the magnesium porphyrazine derived from it (51b) have been prepared either by refluxing a mixture of the
reagents in chloroform in the presence of a molecular sieve or by solvent-free heating in an oven under reduced
pressure. The critical point is whether meso-N-atoms of the porphyrazine core will take part in binding to the
boron group, as shown in Figure 7a, or if only O-donors will form the ester structure, as in Figure 7b. 39

Figure 7. Two possible bonding patterns for the boronic ester of Mg-porphyrazine: tetracoordinated boron (51a) and
tricoordinated boron (51b).

The 11 B NMR spectrum is extremely useful in deciding on the coordination number of boron atoms. It is
a general rule that 4-coordinate boron compounds give a signal around 10 ppm, while in the case of 3-coordinate
compounds it comes out around 30 ppm. 40−42
961
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11

B NMR of porphyrazine molecules is illustrative and simple with a single chemical shift at 28.18 ppm
as a consequence of the tricoordinated boron atom present in the structure. These data provide the critical
proof to decide on the structure where boron atoms are esterified with 2 hydroxyethylthio units without any
interaction with the aza functionalities of the porphyrazine core. 39
6. Carborane-substituted phthalocyanines
Research involving boron-containing phthalocyanines is at a much more elementary stage of development, both
as chemical entities and certainly in terms of their biological evaluation. 10 Only a few boron-containing phthalocyanines have been reported to date and it may be due to their difficult syntheses and purification procedures.
In order to investigate the possible utilization of boronated phthalocyanines as photo-/radiotherapeutic agents
in a combined PDT+BNCT approach to tumor treatment, Fabris et al. 43 prepared a Zn-phthalocyanine peripherally substituted with a dodecaborane (53) through the reaction of borocaptate disodium salt with an
asymmetric anhydride of 2-(4-carboxyphenoxy) phthalocyaninato Zn(II) (52). The reaction was carried out in
anhydrous tetrahydrofuran and the yield was 71% (Scheme 8). 43

Scheme 8. Synthesis of compound 53.

The boronated phthalocyanines appear to be efficient photodynamic sensitizers as no significant variations
can be detected in the quantum yields for the generation of singlet oxygen and in the efficiency of photooxidative
modification of tryptophan. 43
1,8(11),15(18),22(25)- and 2,9(10),16(17),23(24)-tetrasubstituted zinc(II)-phthalocyanines carrying 4 carbon–
carbon linked o-carboranyl units (40 boron atoms, 27.5% boron by weight) were prepared by the tetramerization
of the carborane cage containing phthalocyanine precursors. 44 Phthalonitriles 56 and 57 were synthesized in
satisfactory yields (55% and 48%, respectively) by reaction of the lithium salt of o -carborane with benzyl bromide (54 and 55) in anhydrous THF. The conversion of the phthalonitriles 56 and 57 to the corresponding
Zn(II)-phthalocyanines 58 and 59 was carried out by heating a finely ground mixture of 56 or 57 and zinc
acetate at 220 ◦ C for several hours (Scheme 9). Any attempt to obtain phthalocyanines 58 and 59 by different
962
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methods failed because of the extensive decomposition of the precursors due to the low stability of the carborane
cage towards strong basic conditions. 44

Scheme 9. Synthesis of compounds 56–59.

The investigations focused on a more detailed characterization of the photosensitization pathways involved
in cell inactivation and an exploratory test of its PDT and BNCT activity in mice bearing a tumor known to
be poorly responsive to conventional PDT, such as malignant melanotic melanoma. 45
It was found that the ether bonds connecting the 4 carborane cages to the main tetraazaisoindole
macrocycle were very stable in a variety of biologically relevant media, as well as in cells. The photophysical and
photokinetic properties of carboranyl-carrying phthalocyanine were found to be similar to those typical of other
photodynamically active porphyrin-type photosensitizers, including a singlet oxygen quantum yield of 0.67,
which means that a high fraction of the absorbed photons promote a chemical reaction, namely an oxidative
attack on a variety of cell/tissue constituents, including unsaturated lipids, aromatic and sulfur-containing
amino acid residues, and guanosine bases. 45 In spite of the steric hindrance caused by the bulky p -(methylcarboranyl)phenoxy moieties, ZnB 4 Pc is taken up with a high efficiency by melanotic melanoma cells enough
to induce a statistically significant tumor growth delay upon BNCT treatment. 45
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Two strategies are then obvious for the preparation of a boronated phthalocyanine: 1) attach the boron at
an early stage by placing the boron moiety on the phthalonitrile-“phthalonitrile route”, or 2) add the boron group
to a reactive functional group on a suitably preformed phthalocyanine derivative-“phthalocyanine route”. 46
For the following carborane-substituted phthalocyanines, the “phthalocyanine route” is preferable to the
“phthalonitrile route” because only partial substitution occurs.
o -Carboranyl-substituted phthalocyanine zinc(II) complexes with good solubility in organic solvents were
successfully prepared in good yields from the reaction of substituted phthalocyanine zinc(II) complexes with
polyhedral boron compounds. 47 For the synthesis of the phthalocyanine 62 with an oxymethylene unit between
the phthalocyanine and o -carboranyl groups, 4-nitrophthalonitrile was reacted first with propargyl alcohol to
give the propynyloxy-substituted derivative 60 with 97% yield. The cyclotetramerization of phthalonitrile 60
in n-pentanol with zinc(II) acetate yielded tetrapropynyloxy-substituted phthalocyanine 61 (Scheme 10). The
last step was the reaction of 61 and decaborane in a mixture of acetonitrile and toluene to give the tetra-o carboranyl-substituted phthalocyanine 62 in 33% yield (Scheme 10). 47

Scheme 10. Synthesis of compounds 60–62.

The tetra- o-carboranyl-substituted phthalocyanine (65) was prepared by the reaction of the tetraformylphenoxy-substituted phthalocyanine (63) and 1-bromomethyl-2-lithium-o-carborane (64) generated in situ by
the metalation of bromomethylcarborane with lithium diisoproylamide (Scheme 11). 47
The phthalocyanine derivative 68 with a propylene unit between the positively charged phthalocyanine and the o-carboranyl groups was obtained in a yield of 34% through N-alkylation of 2,9,16,23-tetra-(3pyridyloxy)-phthalocyanine zinc(II) (66) 48 with 1-iodopropyl-2-methylcarborane (67) (Scheme 12). 49 Although
an excess of 67 was used, only mono-alkylation could be achieved. The reason may be a side reaction by attack
of the N-atom of the pyridyl group as a nucleophile at the carborane derivative. 47
o-Carboranyl-substituted phthalocyanines 71 and 74 with an ester or an amide unit between the phthalocyanine and the carboranyl groups had been obtained before from the reaction of 2,9,16,23-tetra-(4hydroxyphenoxy)-phthalocyanine zinc(II) (69) with o -C-carboranyl acetyl chloride (70) or 2,9,16,23-tetra-(4964

ÖZÇELİK and GÜL/Turk J Chem

aminophenoxy)-phthalocyanine zinc(II) (72) with C-methyl-CO-chlorocarbonyl-o-carborane (73) in 53% and
65% yields, respectively (Scheme 13). 50

Scheme 11. Synthesis of compound 65.

Scheme 12. Synthesis of compound 68.

These o-carboranyl substituted phthalocyanine zinc(II) complexes exhibit improved singlet oxygen quantum yields, photooxidative stabilities, and photocatalytic activities compared to phthalocyanine zinc(II) complexes without o -carboranyl groups. Therefore these o -carboranyl complexes are of interest for use in cancer
therapy. 47
The closo-dodecaborate anion has low toxicity and large amounts of boron atoms, and it can be easily produced from 10 B-enriched commercial materials. These advantages make it a good candidate for design of BNCT
agents. A new Zn(II)-phthalocyanine with 8 closo-dodecaborane units (96 boron atoms) (75) was prepared
through a multistep reaction sequence starting with cyclotetramerization of 4-(3,5-dimethoxyphenoxy)phthalonitrile
in the presence of zinc(II) acetate (Figure 8). The conjugate was constructed to estimate its potential as a boron
delivery agent for anticancer boron neutron capture therapy. The boronated phthalocyanine was found to accumulate in A549 human lung adenocarcinoma. 51
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Scheme 13. Synthesis of compounds 71 and 74.

Figure 8. Structures of compounds 75–77.

The electrochemical and spectroelectrochemical properties of metal-free (76) and Co(II) (77)-derivative
of phthalocyanine 75 were also investigated. 52
Water solubility is a goal for many chemists in various fields, as several of the current applications of
phthalocyanines are of biological interest and/or require environmental friendliness, necessitating water solubility
966
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in various ranges of concentrations, pH levels, etc. This is the case of biological and medical applications such
as photodynamic therapy.
The first water-soluble boronated phthalocyanine, bearing only one closo-carborane cage, was synthesized
by Soloway and colleagues. 53 However, no detailed information on its purification and characterization was
reported (Figure 9).

Figure 9. Structure of compound 78.

The phthalonitrile route is preferable for the preparation of soluble phthalocyanines containing carborane
units, since it appeared possible to incorporate a protected solubilizing group, the methyl esters, into the
phthalonitrile and then deprotect in a later step.
A study in 1996 reported the synthesis and characterization of the first boronated metallophthalocyanine in which 4 closo-carborane cages are covalently linked to the periphery of the phthalocyanine ring. 46
Reaction of 4-nitrophthalonitrile with dimethyl malonate in the presence of a base yielded dimethyl(3,4dicyanophenyl)malonate, which was converted into dimethyl(3,4-dicyanophenyl)propargylmalonate (81) by sequential treatment with potassium hydroxide and propargyl bromide. Formation of the o -carborane cage was
accomplished by reaction of the alkyne with decaborane (B 10 H 14 ) in acetonitrile at reflux. High-temperature
solid-state condensation of the resulting o− carboranylphthalonitrile with cobalt(II) chloride followed by ester
deprotection and cation exchange to the sodium salt provided the water-soluble closo-carboranylphthalocyanine
product (85) (Scheme 14). 46
Boron hydride compounds have very different solubility in water: closo-carboranes have exceptionally
hydrophobic characters, whereas nido-carboranes and closo-dodecaborate, due to their anionic nature, are very
soluble as sodium salts. The possible transformation of closo-carborane into nido- provides the possibility to
increase the water solubility of the designed compounds. 14
The first phthalocyanine bearing 8 nido-carborane units, the octaanionic 2,3,9,10,16,17,23,24-octakis
(7-methyl-7,8-dicarba-nido-undecaboran-8-yl)hexylthio-6,13,20,27-(29H,31H)phthalocyanine (86) in the form of
potassium salt, was synthesized through direct cyclization of the corresponding dicyano derivative in the presence
of DBU in a 1:7 molar ratio. DBU is a sufficiently weak nucleophile to limit deboronation to the closo–nido
conversion (Figure 10). 54
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200 °C, 2 h

Scheme 14. Synthesis of compounds 79–85.

Figure 10. Structure of compound 86.

The first A 3 B-type cobaltacarborane-containing Zn(II)-Pcs (91 and 92) was prepared by cyclotetramerization of phthalonitriles 89 and 90 in the presence of an excess of zwitterionic 3,30-Co(8-C 4 H 8 O 2 -1,2C 2 B 9 H 10 )(10,20-C 2 B 9 H 10 ) and anhydrous potassium carbonate in either acetone (in the case of 87) or
in a mixture of acetone/ chloroform 5:1 (in the case of 88). The optimized reaction conditions use a 40-fold
excess of phthalonitrile over a carboranyl-functionalized phthalonitrile (89 or 90) and take advantage of the
easy separation of the target A 3 B-type Pcs from the insoluble (unsubstituted) A 4 -type Pc (Scheme 15). 55
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Scheme 15. Synthesis of compounds 89–92.

Scheme 16. Synthesis of compounds 95 and 96.
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Syntheses of 2 new cobaltacarborane–phthalocyanine conjugates, 1 anionic (95) and 1 zwitterionic (96),
were accomplished via cyclotetramerization of the corresponding cobaltacarborane-substituted phthalonitriles
(93 or 94) with excess phthalonitrile and zinc acetate in quinoline (Scheme 16). 56 The anionic conjugate 95
exists mainly as a monomer in polar organic solvents and has fluorescence quantum yields in the region of
0.2–0.3. The zwitterionic conjugate 96 aggregates in solution and displays lower quantum yields of about 0.1
in organic solvents. 56

7. Phthalocyanines with boronic ester groups
Carbon–carbon bond forming reactions are key steps in the preparation of complex bioactive molecules. One
of the most important carbon–carbon bond-forming methodology is the cross-coupling reaction of organoboron
compounds (Suzuki synthons) with organic electrophiles catalyzed by a palladium (Pd) complex. 57 Pd-catalyzed
coupling reactions of Pc using halogenated Pc templates provide an interesting route to synthesize new families
of unusually elaborated Pc macrocycles. Ali and van Lier 57 reported the synthesis of Pc-boronate and evaluated
its use as a synthon for the Suzuki coupling reaction with various arylhalides for the first time (Scheme 17).
The procedure allows for the synthesis of novel unsymmetrical Pc–Pc heterodimers and a Pc-based branched
triad, that is, Pc–(Pc) 2 (Schemes 18 and 19). 57

Scheme 17. Synthesis of phthalocyanine-borane synthon (98) and its reaction with aryl halides.
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Scheme 18. Synthesis of phthalocyanine-phthalocyanine hetero-dimer (101).

The rhodium-catalyzed carbon–carbon bond forming reaction using phthalocyanine-boronate ester is a
powerful tool for further derivatization of Pc. In 2013, Ali and van Lier 58 reported the use of Rh-catalyzed
transformations for the synthesis of Pc derivatives for the first time (Scheme 20).
A new covalent organic framework (PBBA COF) (108) featuring a square lattice composed of phthalocyanine macrocycles joined by phenylene bis(boronic acid) linkers was prepared by combining phthalocyanine
106, 1,4-phenylenebis(boronic acid) (PBBA) (107), and BF 3 .OEt 2 (0.015 mL) in a 1:1 mixture of mesitylene
and 1,2-dichloroethane in a flame-sealed glass reaction vessel placed in a 120 ◦ C oven for 6 days (Scheme 21).
The material’s broad absorbance over the solar spectrum, potential for efficient charge transport through the
stacked phthalocyanines, good thermal stability, and modular nature of COF synthesis showed strong promise
for applications in organic photovoltaic devices. 59
Nickel phthalocyanine-based COF (NiPc COF) (110) was synthesized by the boronate esterification reaction of (2,3,9,10,16,17,23,24-octahydroxyphthalocyaninato)-nickel(II), [(OH) 8 PcNi] (109), and 1,4-benzenediboronic acid (107) in dimethylacetamide (DMAc)/o-dichlorobenzene under solvothermal conditions (Scheme 22).
These 2D COFs provide preorganized conduction paths based on precise ordering of the phthalocyanine stack
and are ideal for charge carrier transport. 60
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Scheme 19. Synthesis of phthalocyanine-(phthalocyanine) 2 homo-triad (103).

Scheme 20. Synthesis of compounds 104 and 105.
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Scheme 21. Synthesis of compound 108.

Farfán and colleagues 61 investigated the imino Diels Alder reactions with organoboron esters prepared
by the condensation of the salicylaldimines with phenylboronic acid (PhB(OH) 2 ) or diphenylborinic acid
(Ph 2 BOH) and discovered that related systems are potential candidates for third-order nonlinear optical
studies. 61 4-(4-Formyl-3-hydroxyphenoxy)phthalonitrile and its condensation product with 2-aminophenol have
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been synthesized to reach 4-(3-hydroxy-4-(((2-hydroxyphenyl)imino)-methyl)phenoxy)phthalonitrile (111), a
tridentate ligand possessing ONO binding sites. Subsequent condensation of phenylboronic acid with 111
afforded a novel boronic ester of a Schiff base with a phthalonitrile group (112) (Figure 11). Boronate 112
displays high stability and can be handled in air due to the presence of coordinative B-N and covalent B-O
bonds in its structure. 62

Scheme 22. Synthesis of compound 110.
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ÖZÇELİK and GÜL/Turk J Chem

Figure 11. Structure of compounds 111 and 112.

The first Zn phthalocyanine bearing 4 phenylboronic azaester substituents at peripheral positions (116)
and the phenylboronic azaester of its precursor, namely 4-(2-(2-phenyl-1,3,6,2-dioxazaborocan-6-yl)ethoxy)phthalonitrile (114), were synthesized as seen in Scheme 23.
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Scheme 23. Synthesis of compounds 113–116.

4-[2-(bis(2-Hydroxyethyl)amino)ethoxy]phthalonitrile (113) was synthesized by the aromatic nucleophilic
substitution reaction of 4-nitrophthalonitrile with triethanolamine. 2,9(10),16(17),23(24)-Tetrakis[2-(bis(hydroxyethyl)amino)ethoxy]phthalocyaninato-zinc(II) (115) was prepared from the cyclotetramerization of dinitrile
113 in the presence of anhydrous zinc(II) acetate by microwave irradiation. Treatment of phthalocyanine 115
with phenylboronic acid in a mixture of DMSO/toluene (20/1, v/v) afforded the desired phthalocyanine 116.
The complexation reaction of precursor 113 and phenylboronic acid in ethyl acetate under reflux conditions
yielded the desired dioxazaborocane 114. It was demonstrated that the boron atom of phthalonitrile 114 is in
the tetracoordinated state with the formation of a coordinative N-B bond (closed form), while in the case of
phthalocyanine 116, the open conformer possessing a tricoordinated boron atom is favored. 63
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Esters of boronic acids are notoriously unstable to hydrolysis. 64 However, organoboran compounds with
a boroxazolidine ring in their structure exhibited high hydrolytic stability. This notable increase in hydrolytic
stability is ascribed to the formation of a B-N coordinative bond. 65 Furthermore, compounds containing B-N
bonds have been shown to possess biological activity. In this respect synthesis of zinc phthalocyanine substituted
with boronic acid ester of Schiff base groups was reported for the first time. 66
As the first step, the Schiff base product (118) was obtained from the reaction of salicylaldehyde
with 2,9(10),16(17),23(24)-tetra-(4-[4-aminophenoxy])-phthtalocyaninatozinc(II) (117) in THF under argon
atmosphere. The Schiff base structure obtained from the reaction of salicylaldehyde with amine groups of
compound 117 presents 2 active sites to the boron reagent: the OH group, which can form boron esters, and
the nitrogen, which can give N-B coordination compounds. 67 Treatment of compound 118 with benzeneboronic
acid in ethanol/toluene mixture at reflux temperature afforded the phthalocyanine 119 substituted peripherally
with 4 benzeneboronic acid esters of Schiff base groups in high yield (Scheme 24). Spectrophotometric data
indicated that the boron atom in the boronate groups is in the tetracoordinated state with formation of a
coordinative N-B bond. 66

Scheme 24. Synthesis of compounds 118 and 119.
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Addition of boron-containing moieties including carboranes, dodecaboranes, and boronic esters to tetrapyrrole derivatives provides a rich group of chemicals applicable to PDT, BNCT, coupling reactions, etc.
In conclusion, we have tried to summarize recent works on new interesting materials composed of
phthalocyanine, porphyrin, or porphyrazine moieties on one side and boron-containing substituents (e.g.,
carborane, decaborane, boronic ester, borinic ester) on the other. These combinations are applicable to
products exceptionally useful in a variety of fields, from medical applications such as BNCT or PDT to organic
photovoltaic devices. As Turkey is a country rich in boron minerals, practical advice to qualified synthetic
chemists on phthalocyanines can be to combine advanced materials properties of tetrapyrrole derivatives with
boron-containing groups.
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